Pientzehuang Pharmaceutical shareholders approve key resolutions, board changes

Zhangzhou Pientzehuang Pharmaceutical Co. announced its first extraordinary general meeting of shareholders for 2025 took place on December 9, 2025. A total of 1,576 shareholders and their proxies attended, representing 357,789,820 voting shares, or 59.3037% of the company's total voting shares. All resolutions, including special and ordinary ones, were approved.

Key resolutions passed included the removal of the supervisory committee and amendments to the company's articles of association, the revision of the rules of procedure for shareholders' meetings, the revision of the rules of procedure for board meetings, and the appointment of new non-independent directors. The resolution for removing the supervisory committee and amending the articles of association garnered 351,024,517 affirmative votes (98.1091%), with 6,623,803 votes against (1.8513%).

The resolution for revising the rules of procedure for shareholders' meetings received 351,546,402 affirmative votes (98.2550%). The meeting also approved the revision of the rules of procedure for board meetings with 351,506,203 affirmative votes (98.2437%) and the proposal to add non-independent directors with 357,314,786 affirmative votes (99.8672%). Furthermore, amendments to the company's investment and financing management system were also approved. The resolutions were confirmed to comply with relevant company laws and regulations, as validated by Taihetai (Beijing) Law Firm.